Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW Pattern

Trial N/A Terminated Jan. 31, 2024

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Trial N/A Unknown Jan. 31, 2024

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Trial Phase 4 Unknown Jan. 31, 2024

Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

Trial N/A Unknown Jan. 30, 2024

Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study

Trial N/A Active, not recruiting Jan. 30, 2024

The Effects of Sertraline on Depression in Parkinson's Disease

Trial N/A Completed Jan. 29, 2024

Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease

Trial N/A Completed Jan. 28, 2024

DBS Imaging-based vs. Threshold Assessment-based Programming

Trial N/A Unknown Jan. 24, 2024

Investigation of the Effects of LSVT-BlG Protocol on Balance, Gait, Fatigue and Quality of Life in Parkinson's Patients

Trial N/A Completed Jan. 21, 2024

Driving Performance of People With Parkinson's Using Autonomous In-Vehicle Technologies

Trial N/A Completed Jan. 18, 2024

Move to Improve Physical Activity in Parkinson's Disease

Trial N/A Completed Jan. 18, 2024

Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers

Trial Phase 1 Completed Jan. 17, 2024

A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

Trial Phase 1 Completed Jan. 17, 2024

A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612

Trial Phase 2 Completed Jan. 17, 2024

Quality-of-Life Index (Q-Index)

Trial N/A Unknown Jan. 16, 2024

Usability of a Novel Cueing Device for Patients With Parkinson's Disease

Trial N/A Unknown Jan. 11, 2024

An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States

Trial Phase 2 Completed Jan. 10, 2024

Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System

Trial N/A Terminated Jan. 9, 2024

Individual Neuromodulation for PDS

Trial N/A Unknown Jan. 9, 2024

Deep Brain Stimulation Lead Localization After Implantation

Trial N/A Unknown Jan. 8, 2024